Blackstone Other Non-Current Liabilities increased by 0.6% to $3.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.5%, from $3.36B to $3.24B. Over 3 years (FY 2022 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 15.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.12B | $2.09B | $2.19B | $2.39B | $2.14B | $2.36B | $2.62B | $2.81B | $3.36B | $2.80B | $3.00B | $3.22B | $3.24B |
| QoQ Change | — | -1.2% | +4.6% | +9.4% | -10.8% | +10.7% | +10.8% | +7.2% | +19.7% | -16.6% | +7.0% | +7.5% | +0.6% |
| YoY Change | — | — | — | +13.0% | — | +13.0% | +19.8% | +17.3% | +57.4% | +18.5% | +14.5% | +14.8% | -3.5% |